Applications of PET imaging with radiolabelled choline (11C/18F-choline)

被引：2
作者：
Kirienko, M. [1 ]
Sollini, M. [2 ]
Lopci, E. [3 ]
Versari, A. [2 ]
Chiti, A. [3 ]
机构：
[1] Milano Bicocca Univ, Dept Nucl Med, Milan, Italy
[2] IRCCS, Arcispedale Santa Maria Nuova, Dept Oncol & Adv Technol, Nucl Med Unit, Reggio Emilia, Italy
[3] Humanitas Res Hosp, Dept Nucl Med, Rozzano, MI, Italy
来源：
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 59卷 / 01期
关键词：
Choline; Positron emission tomography; Computed tomography; Neoplasms; POSITRON-EMISSION-TOMOGRAPHY; PROSTATE-CANCER PATIENTS; SALVAGE RADIATION-THERAPY; HEPATOCELLULAR-CARCINOMA; C-11; CHOLINE; C-11-CHOLINE PET/CT; RADICAL PROSTATECTOMY; BIOCHEMICAL RELAPSE; BRAIN-TUMORS; FDG-PET;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The use of radiopharmaceuticals is the distinguishing characteristics of nuclear medicine. Among the panel of available radiopharmaceuticals in many PET centers around the world, choline is well represented, being widely used to image prostate cancer. Carbon-11 labelled choline can only be produced in centres with a cyclotron available, but the F-18-labelled radiopharmaceutical is distributed and licensed in several countries in Europe. Besides prostate cancer, other possible uses of choline are related to its ability to indirectly evaluate the cell proliferation as a measure of the synthesis of lipids required for cell membrane. In particular, the radiopharmaceutical can be successfully used in those districts where F-18-FDG has a high uptake, like the brain. Moreover, slow growing tumors, not always taking up F-18-FDG, like hepatocellular carcinoma, can also be imaged. We will evaluate possibly uses of this molecule in patients affected by prostate cancer, brain tumors and hepatocellular carcinoma.
引用
收藏
页码：83 / 94
页数：12
相关论文
共 55 条
[1]   18F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients [J].
Beheshti, Mohsen ;
Imamovic, Larisa ;
Broinger, Gabriele ;
Vali, Reza ;
Waldenberger, Peter ;
Stoiber, Franz ;
Nader, Michael ;
Gruy, Bernhard ;
Janetschek, Guenter ;
Langsteger, Werner .
RADIOLOGY, 2010, 254 (03) :925-933
[2]  
Bolog N, 2011, J GASTROINTEST LIVER, V20, P181
[3]   Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis [J].
Bolondi, L ;
Sofia, S ;
Siringo, S ;
Gaiani, S ;
Casali, A ;
Zironi, G ;
Piscaglia, F ;
Gramantieri, L ;
Zanetti, M ;
Sherman, M .
GUT, 2001, 48 (02) :251-259
[4]  
Calabria F, 2014, CLIN NUCL MED, V39, P122, DOI 10.1097/RLU.0000000000000303
[5]   Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging 11C-Choline PET/CT Scan Before Salvage Radiation Therapy? [J].
Castellucci, Paolo ;
Ceci, Francesco ;
Graziani, Tiziano ;
Schiavina, Riccardo ;
Brunocilla, Eugenio ;
Mazzarotto, Renzo ;
Pettinato, Cinzia ;
Celli, Monica ;
Lodi, Filippo ;
Fanti, Stefano .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (09) :1424-1429
[6]   Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome [J].
Chen, WT ;
Chau, GY ;
Lui, WY ;
Tsay, SH ;
King, KL ;
Loong, CC ;
Wu, CW .
EJSO, 2004, 30 (04) :414-420
[7]  
de Jong IJ, 2003, J NUCL MED, V44, P331
[8]   Visualization of prostate cancer with 11C-choline positron emission tomography [J].
de Jong, IJ ;
Pruim, J ;
Elsinga, PH ;
Vaalburg, W ;
Mensink, HJA .
EUROPEAN UROLOGY, 2002, 42 (01) :18-23
[9]   Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer A Systematic Review and Meta-Analysis [J].
Evangelista, Laura ;
Zattoni, Fabio ;
Guttilla, Andrea ;
Saladini, Giorgio ;
Zattoni, Filiberto ;
Colletti, Patrick M. ;
Rubello, Domenico .
CLINICAL NUCLEAR MEDICINE, 2013, 38 (05) :305-314
[10]  
Farsad M, 2005, J NUCL MED, V46, P1642
123456